PELZARDA
Live / Registered — Registered (as of 04 Jan 2022)
What this means for you
Registered since 04 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79313583
- Registration number
- 6604623
- Mark type
- Stylized text
- Filed
- 30 Apr 2021
- Published for opposition
- 19 Oct 2021
- Registered
- 04 Jan 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 29 May 2022 — NOTIFICATION PROCESSED BY IB
- 03 May 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 03 May 2022 — FINAL DISPOSITION PROCESSED
- 03 Feb 2022 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 31 Jan 2022 — TEAS SECTION 7 REQUEST RECEIVED
- 04 Jan 2022 — CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
- 04 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 23 Nov 2021 — CORRECTION TRANSACTION RECEIVED FROM IB
- 19 Oct 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Oct 2021 — PUBLISHED FOR OPPOSITION
- 29 Sept 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Sept 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Sept 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Sept 2021 — ASSIGNED TO EXAMINER